ChemoCentryx
CCXI
#3560
Rank
โ‚น336.13 B
Marketcap
โ‚น4,674
Share price
0.00%
Change (1 day)
41.98%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): โ‚น2.82 Billion

According to ChemoCentryx's latest financial reports the company's current revenue (TTM ) is โ‚น3.34 Billion. In 2021 the company made a revenue of โ‚น2.37 Billion a decrease over the revenue in the year 2020 that were of โ‚น4.70 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น2.82 B19.07%
2021 โ‚น2.37 B-49.58%
2020 โ‚น4.70 B83.68%
2019 โ‚น2.56 B-14.48%
2018 โ‚น2.99 B-43.09%
2017 โ‚น5.26 B577.87%
2016 โ‚น0.77 B
2015 N/A
2014 N/A-100%
2013 โ‚น0.37 B26.18%
2012 โ‚น0.29 B-82.29%
2011 โ‚น1.67 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
โ‚น904.88 B 26,958.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น5.361 T 160,233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.807 T 113,751.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
โ‚น4.318 T 129,023.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.283 T 247,612.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.233 T 96,596.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.644 T 168,679.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.508 T 44,996.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
โ‚น5.774 T 172,574.73%๐Ÿ‡บ๐Ÿ‡ธ USA